No insider purchase over the last 90 days. The latest, by 이재복, was filed 10 Jun 2026.
Who traded when
BuySale+17 other insiders
Since the insiders bought
- +0.3%Entry ₩15,900 · Close 30 Oct 2026 ₩15,940
- +0.3%Entry ₩15,900 · Close 30 Oct 2026 ₩15,940
- +2.9%Entry ₩14,360 · Close at T+90 ₩14,780
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate HITEJINRO Co., Ltd. Buy (bullish), based on 6 analysts. Average price target: ₩19,833.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 1,000 sharesShareKRXDART:20260610000094Canonical exit: 8 Sept 2026 (T+90)
- 1,210 sharesKRXDART:20260608000077Canonical exit: 6 Sept 2026 (T+90)
- 1,000 sharesShareKRXDART:20260608000073Canonical exit: 6 Sept 2026 (T+90)
- 1,200 sharesShareKRXDART:20260608000066Canonical exit: 6 Sept 2026 (T+90)
- 1,070 sharesShareKRXDART:20260608000070Canonical exit: 6 Sept 2026 (T+90)
- 3,000 shares@ ₩16,460.000.0044% mcap100.0% of flowShareKRXDART:20260529000890Canonical exit: 24 Aug 2026 (T+90)
- 800 shares@ ₩16,800.000.0012% mcap100.0% of flowShareKRXDART:20260529000900Canonical exit: 25 Aug 2026 (T+90)
- 1,000 sharesShareKRXDART:20260522000188Canonical exit: 20 Aug 2026 (T+90)
- 4,759 sharesKRXDART:20260522000190Canonical exit: 16 Aug 2026 (T+90)
- 1,000 sharesShareKRXDART:20260522000187Canonical exit: 20 Aug 2026 (T+90)
- 2,000 sharesShareKRXDART:20260522000185Canonical exit: 20 Aug 2026 (T+90)
- 1,000 sharesShareKRXDART:20260522000178Canonical exit: 20 Aug 2026 (T+90)
- 1,234 sharesShareKRXDART:20260522000182Canonical exit: 20 Aug 2026 (T+90)
- 1,000 sharesShareKRXDART:20260522000186Canonical exit: 20 Aug 2026 (T+90)
- 1,000 sharesShareKRXDART:20260522000183Canonical exit: 20 Aug 2026 (T+90)
- 708,984 sharesKRXDART:20260518000239
- 720 sharesShareKRXDART:20260518000233Canonical exit: 16 Aug 2026 (T+90)
- 2,500 sharesShareKRXDART:20260518000231Canonical exit: 16 Aug 2026 (T+90)
- 1,000 sharesShareKRXDART:20260518000229Canonical exit: 16 Aug 2026 (T+90)
- 1,500 sharesShareKRXDART:20260518000227Canonical exit: 16 Aug 2026 (T+90)
- 1,000 sharesShareKRXDART:20260518000238Canonical exit: 16 Aug 2026 (T+90)
- 2,000 sharesShareKRXDART:20260518000235Canonical exit: 16 Aug 2026 (T+90)
- 1,111 sharesShareKRXDART:20260518000234Canonical exit: 16 Aug 2026 (T+90)
- 1,000 sharesShareKRXDART:20260518000225Canonical exit: 16 Aug 2026 (T+90)
- 5,000 sharesShareKRXDART:20260518000208Canonical exit: 16 Aug 2026 (T+90)
25 of 54 declarations
About HITEJINRO Co., Ltd.
Between May 18 and June 10, 2026, 22 distinct filers bought shares of 하이트진로 (HITEJINRO Co., Ltd.), a South Korean food and beverage company listed on the Korea Exchange. It is the busiest buying window in the record, which holds 54 filings published between March 11, 2021 and June 10, 2026. Insiders hold 54.1% of the capital, against a market capitalisation of KRW 1,115.1 billion.
Across the whole history there are 37 purchases and 12 sales, or 76% purchases among open-market trades. Only two purchases carry an amount, EUR 35,818 in all: EUR 28,147 for 신민철 on May 26, 2026 and EUR 7,672 for 박연규 the next day. Among the most frequent filers, 백정훈 (상무보) filed 12 times, all purchases, while 국민연금공단 has 13 filings, 11 of them sales.
Read moreShow less
Activity is concentrated in 2026, with 27 filings against 3 in 2025. Over the last twelve months there are 30 filings, of which 25 purchases and 3 sales. Filings are published a median of 6 days after the trade. For 21 purchases a 90-day result is stored: a median of minus 5.6%, with 38% of results positive. These are recorded past results, not a forecast.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
